Does Centene Ambetter Cover Rybelsus? Medicare Advantage Coverage Guide 2026
Seniors on Medicare Advantage through Ambetter Medicare (administered by Centene Corporation) often ask whether their plan covers Rybelsus (oral semaglutide). In brief: coverage depends on several plan-specific factors.
Centene Ambetter’s Formulary Position on Rybelsus
Ambetter Medicare maintains a prescription drug list that categorizes medications into cost-sharing tiers. Currently, Rybelsus is typically placed on Tier 5 (Non-preferred specialty) on most Centene Ambetter plan designs.
Cost implications:
- Out-of-pocket cost: significant cost-sharing varying by your specific plan design
- Prior authorization: Yes — clinical documentation must be provided
- Quantity limits: Common — limited to FDA-recommended dosing
- Step therapy: Might need trying first-line therapies first
In the donut hole phase, cost-sharing increases to 25% of Rybelsus’s cost until catastrophic coverage kicks in.
Coverage for Different Indications
For type 2 diabetes (FDA-approved):
- Centene Ambetter will generally authorize Rybelsus with appropriate documentation
- Documentation needed: HbA1c levels, prior medication history
- Approval rates are higher for the FDA-approved indication
For weight loss (for chronic weight management):
- CMS policy generally prohibits anti-obesity medications under Part D
- An exception exists: 2025 policy changes expanded formulary inclusion rules for certain anti-obesity drugs
- Centene Ambetter might include additional drug benefits that cover weight management medications — review your plan’s specific formulary
Estimated Costs With Centene Ambetter
Understanding your out-of-pocket cost for Rybelsus on Centene Ambetter involves your current coverage phase.
| Coverage Phase | Typical Cost |
|---|---|
| Initial Deductible ($545 in 2026) | You pay everything: $900–$1,100/month |
| Initial Coverage | Tier 4/5 copay |
| Coverage Gap (Donut Hole) | 25% of cost |
| Catastrophic Coverage | $0 or small copay |
Thanks to the Inflation Reduction Act, total OOP costs won’t exceed $2,000 — a major benefit for GLP-1 users.
How to Maximize Coverage
- Apply for an exception — When cost is prohibitive, your provider can request a tier reduction or formulary exception with clinical justification
- Apply for patient assistance — Novo Nordisk provides patient assistance programs for qualifying patients (government plan restrictions may apply)
- Shop during AEP — Open enrollment (Oct 15–Dec 7) lets you find a better-tier placement
- Check Low-Income Subsidy eligibility — For qualifying individuals can get reduced Part D costs that slash out-of-pocket expenses